COVID-19 - International Pharmaceutical Industry

News

Late cancer diagnoses rise as NHS struggles with COVID-19

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-1...

1 December 2021 News breast cancer | cancer

Continue Reading →

Volume 13 Issue 4

The Brave New World of Rapid Drug Development

The COVID-19 pandemic has brought the topic of rapid drug development to the forefront of the life sciences sector. Ray Chohan at PatSnap, believes that we have ente...

24 November 2021 Volume 13 Issue 4 COVID-19 | drug development

Continue Reading →

Volume 13 Issue 4

The New Normal: How COVID-19 Became the Catalyst for Change

When COVID-19 disrupted life sciences, solutions were needed in real-time. As the pandemic grew, so did the need to innovate. Workers met the challenges. They comple...

24 November 2021 Volume 13 Issue 4 COVID-19 | disruptive technologies in life sciences

Continue Reading →

Volume 13 Issue 4

Behavioural Science: An Untapped Opportunity for Medical Affairs

Just proving that an intervention has benefits is not always enough for it to be adopted into clinical practice. Yet in the past, pharma Medical Affairs teams have l...

24 November 2021 Volume 13 Issue 4 Affairs | clinical

Continue Reading →

News

EC approves Celltrion’s COVID-19 mAb Regkirona

The European Commission (EC) has authorised Celltrion’s COVID-19 monoclonal antibody (mAb) treatment Regkirona (regdanvimab, CT-P59), the company announced yesterday...

17 November 2021 News Celltrion | COVID-19

Continue Reading →

News

Pfizer signs deal to allow expanded use of COVID-19 treatment

Pfizer has signed a new deal with UN-backed organisation the Medicines Patent Pool (MPP) to increase access to its COVID-19 treatment for low- and middle-income coun...

17 November 2021 News antiviral treatment | COVID-19

Continue Reading →

News

JCVI updates its COVID-19 booster vaccination guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has updated its guidance and is now advising that all adults aged 40 to 49 should also be offered a booste...

17 November 2021 News booster vaccination | COVID-19

Continue Reading →

News

First authorisation for Novavax COVID-19 jab announced

Novavax has received the first emergency use authorisation (EUA) for its COVID-19 vaccine in Indonesia, with the company adding it is expecting further authorisation...

3 November 2021 News COVID-19 | Indonesia

Continue Reading →

News

Pfizer and BioNTech announce Phase 3 trial data showing high efficacy of a booster dose of their COVID-19 vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a ...

27 October 2021 News BioNTech | booster dose

Continue Reading →

News

UK COVID-19 patients able to take GP prescribed medicine at home

COVID sufferers in the UK are now able to access a course of tablets from their GP to avoid the need for hospitalisation. AiPharma’s antiviral treatment, favipiravir...

27 October 2021 News AiPharma | antiviral

Continue Reading →